2m 2m 2m 2m 2m 2m 2m
NEUROGENE (NGNE)
NASDAQ
$35.53+$0.05 (+0.13%)
Price as of Sep 11, 2026 7:30 PM EDT- $710.0MMarket Cap
- 86.74%1-Year Change
- BiotechnologyIndustry
NEUROGENE (NGNE)
$35.53+$0.05 (+0.13%)
NGNE | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $35.48 | ||
Change | -$0.64 (-1.77%) | ||
Open | $36.50 | ||
High | $37.64 | ||
Low | $35.38 | ||
Previous Close | $36.12 | ||
Volume | 181,388 | ||
30-Day Average Volume | 217,632 | ||
1-Week Change | -8.08% | ||
1-Month Change | -0.89% | ||
1-Year Change | 86.74% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 20.0M | ||
Total Assets | $244.4M | ||
Market Cap | $710.0M | ||
Enterprise Value | $597.5M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$34.5M | ||
Free Cash Flow | -$24.1M | ||
EBIT | -$34.5M | ||
EBITDA | -$33.7M | ||
Net Working Capital | $207.4M | ||
EPS | -$1.53 | ||
Enterprise Value/EBITDA | -18 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 3 | ||
P/E | -23 | ||
PEG | 2 | ||
Price/Free Cash Flow | -29 | ||
Price/Operating Cash Flow | -30 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 5 | ||
Last Split Date | 09/25/2023 | ||
Earnings & Revenue